Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$900M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$866M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$596M |
| 4 |
Clarivate
CLVT
|
+$284M |
| 5 |
Mastercard
MA
|
+$272M |
Top Sells
| 1 |
Wolfspeed
WOLF
|
+$1.11B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1,000M |
| 3 |
Apple
AAPL
|
+$925M |
| 4 |
Intel
INTC
|
+$462M |
| 5 |
Microsoft
MSFT
|
+$435M |
Sector Composition
| 1 | Technology | 25.57% |
| 2 | Financials | 13.1% |
| 3 | Healthcare | 12.32% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Aligos Therapeutics
ALGS
$77.2M
| $1.37M | ﹤0.01% |
3,529
+960
| +37% | +$372K |
|
2827
Spero Therapeutics
SPRO
$111M
| $1.36M | ﹤0.01% |
71,121
+7,079
| +11% | +$136K |
|
2828
Rush Enterprises Class B
RUSHB
$4.59B
| $1.36M | ﹤0.01% |
45,323
+68
| +0.2% | +$2.04K |
|
|
ICVX
2829
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $1.36M | ﹤0.01% |
+45,921
| New | +$1.36M |
|
|
MRNS
2830
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.36M | ﹤0.01% |
119,323
-9,133
| -7% | -$104K |
|
|
CNBKA
2831
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $1.36M | ﹤0.01% |
11,873
+32
| +0.3% | +$3.66K |
|
2832
Forte Biosciences
FBRX
$138M
| $1.35M | ﹤0.01% |
1,894
+144
| +8% | +$103K |
|
2833
Willdan Group
WLDN
$1.39B
| $1.35M | ﹤0.01% |
38,570
+1,484
| +4% | +$52.1K |
|
2834
Lifecore Biomedical
LFCR
$273M
| $1.35M | ﹤0.01% |
146,378
-22,601
| -13% | -$208K |
|
|
PARAA
2835
DELISTED
Paramount Global Class A
PARAA
| $1.35M | ﹤0.01% |
32,041
-1,346
| -4% | -$56.6K |
|
2836
Aemetis
AMTX
$143M
| $1.34M | ﹤0.01% |
91,347
+4,834
| +6% | +$71.1K |
|
2837
Spyre Therapeutics
SYRE
$1B
| $1.34M | ﹤0.01% |
7,186
-185
| -3% | -$34.5K |
|
|
AKTS
2838
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $1.34M | ﹤0.01% |
135,543
+3,643
| +3% | +$36.1K |
|
2839
Southern First Bancshares
SFST
$369M
| $1.34M | ﹤0.01% |
26,918
-93
| -0.3% | -$4.62K |
|
2840
Full House Resorts
FLL
$120M
| $1.33M | ﹤0.01% |
154,650
+11,205
| +8% | +$96.6K |
|
2841
AXT Inc
AXTI
$140M
| $1.33M | ﹤0.01% |
167,872
+3,303
| +2% | +$26.2K |
|
|
BNR
2842
Burning Rock Biotech
BNR
$97.5M
| $1.33M | ﹤0.01% |
7,440
+500
| +7% | +$89.4K |
|
2843
Rafael Holdings
RFL
$47M
| $1.33M | ﹤0.01% |
36,504
-1,051
| -3% | -$38.2K |
|
2844
908 Devices
MASS
$204M
| $1.32M | ﹤0.01% |
36,922
+19,508
| +112% | +$700K |
|
|
VIRX
2845
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.32M | ﹤0.01% |
151,458
+3,724
| +3% | +$32.5K |
|
2846
W&T Offshore
WTI
$260M
| $1.32M | ﹤0.01% |
399,215
-12,066
| -3% | -$39.8K |
|
|
RRD
2847
DELISTED
RR Donnelley & Sons Co.
RRD
| $1.32M | ﹤0.01% |
300,351
-603
| -0.2% | -$2.64K |
|
2848
Seneca Foods Class A
SENEA
$765M
| $1.31M | ﹤0.01% |
27,517
-3,895
| -12% | -$186K |
|
2849
SoundThinking
SSTI
$156M
| $1.31M | ﹤0.01% |
36,046
+6,943
| +24% | +$253K |
|
2850
Southern Missouri Bancorp
SMBC
$651M
| $1.31M | ﹤0.01% |
31,111
-1,502
| -5% | -$63.2K |
|